Skip to main content
SpringerLink
Log in

Insulintherapie

  • Chapter
Diabetes bei Kindern und Jugendlichen

  • 1118 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Banting FG, Best CH (1922) Pancreatic extracts. J Lab Clin Med 7: 464–472

    CAS  Google Scholar 

  • Berson SA, Yalow RS (1959) Quantitative aspects of the reaction between insulin and insulin-binding antibody. J Clin Invest 39: 1996

    Google Scholar 

  • Bertram F (1953) Klinische Beobachtungen über neue verzögernd wirkende Insulinpräparate. Verh Dtsch Ges Inn Med 59: 242

    Google Scholar 

  • Bolli GB, Owens DR (2000) Insulin glargine. Lancet 356: 443–445

    Article  PubMed  CAS  Google Scholar 

  • Brange J, Owens DR, Kang S, Solund A (1990) Monomeric insulins and their experimental and clinical implications. Diabetes Care 13: 923–954

    PubMed  CAS  Google Scholar 

  • Chance RE, Kroeff EP, Hoffmann JA, Frank BH (1981) Chemical, physical and biologic properties of biosynthetic human insulin. Diabetes Care 4: 147–154

    PubMed  CAS  Google Scholar 

  • Danne T, Deiss D, Hopfenmüller W, von Schütz W, Kordonouri O (2002) Experience with insulin analogues in children. Horm Res 57 (Suppl. 1): 46–53

    Article  PubMed  CAS  Google Scholar 

  • Danne T, Lüpke K, Walte N, von Schütz W, Gall MA (2003) Insulin detemir is characterized by a consistent pharmacokinetic profile across age groups in children, adolescents and adults with type 1 diabetes. Diabetes Care 26: in press

    Google Scholar 

  • Field JB (1973) Extraction of insulin by liver. Am Rev Med 24: 309

    Article  CAS  Google Scholar 

  • Goeddel DV, Kleid DG, Bolivar F et al. (1979) Expression in Escherichia coli of chemically synthesized genes for human insulin. Proc Natl Acad Sci USA 76: 106–110

    Article  PubMed  CAS  Google Scholar 

  • Hagedorn HC, Jensen BN, Krarup NB, Wodstrup I (1936) Protamine insulinate. JAMA 106: 177–180

    CAS  Google Scholar 

  • Hallas-Møller K, Petersen K, Schlichtkrull J (1952) Crystalline and amorphous insulin-zinc compounds with prolonged action. Science 116: 394–399

    Article  Google Scholar 

  • Heinemann L, Breuer J, Cebulla D, Wüssel B, Bender R, Heise T (1996) Wirkprofil von Normalinsulin, 25/75-Mischinsulin und NPH-Insulin, hergestellt aus gentechnologischem oder semisynthetischem Humaninsulin. Diabetes und Stoffwechsel 5: 157–163

    Google Scholar 

  • Heinemann L, Heise T (2001) Klinische Wirkungen und Pharmakodynamik der Insulin-Analoga Lispro, Aspart und Glargin. Dtsch Med Wschr 126: 597–604

    Article  PubMed  CAS  Google Scholar 

  • Heinemann L, Weyer C, Rave K, Rauhaus M, Stiefelhagen O, Heise T (1997) Comparison of the time action profile of U40-and U100-regular human insulin and rapid-acting insulin analogue B28 Asp. Exp Clin Endocrinol Diabetes 105: 131–135

    Google Scholar 

  • Heinemann L, Woodworth JR (1998) Insulin Lispro; Chapter III: Pharmacokinetics and Metabolism of Insulin Lispro. Drugs of Today 34(Suppl. C): 23–36

    CAS  Google Scholar 

  • International Society for Pediatric and Adolescent Diabetes (ISPAD), International Diabetes Federation World Health Organisation (2000) Consensus guidelines for the management of insulin-dependent (type I) diabetes mellitus (IDDM) in childhood and adolescence. PGF Swift. Publ. Medforum (ed), Zeist, Niederlande. http://www.ispad.org, deutsche Fassung: http://www.disetronic.de/download/ 0701_B_ISPAD.pdf

    Google Scholar 

  • Johnson IS (1983) Human insulin from recombinant DNA technology. Science 219: 632

    PubMed  CAS  Google Scholar 

  • Kellerer M, Häring HU (2001) Insulin analogues: impact of cell model characteristics on results and conclusions regarding mitogenic properties. Exp Clin Endocrinol Diabetes 109: 63–64

    Article  PubMed  CAS  Google Scholar 

  • Krayenbühl C, Rosenberg T (1946) Crystalline protamine insulin. Rep Steno Mem Hosp Nord Insulinlab 1: 60–73

    Google Scholar 

  • Kriegstein E von (2004) Insulin-Tabelle XII/2003. Diabetes und Stoffwechsel 12: 221–224

    Google Scholar 

  • Kurtzhals P, Schaffer L, Sorensen A, Kristensen C, Jonassen I, Schmid C, Trub T (2000) Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 49: 999–1005

    PubMed  CAS  Google Scholar 

  • Markussen J, Damgaard U, Jørgensen KH, Rasmussen E, Snel L, Thim L, Voigt HO (1982) Production of human monocomponent insulin. In: Hormone Drugs. Gueriguian IL, Bransome ED, Outschoorn AS (eds) Rockville, MD, U.S. Pharm. Conv., p. 116–126

    Google Scholar 

  • Obermeier R, Geiger R (1976) A new semisynthesis of human insulin. Hoppe Seylers Z Physiol Chem: 357–759

    Google Scholar 

  • Schatz H, Bottermann P, von Kriegstein E (2000) Insulin-Tabelle 2000. Deutsche Diabetes-Gesellschaft Bochum

    Google Scholar 

  • Schlichtkrull J, Brange J, Christiansen AH, Hallund O, Heding LG, Jørgensen KH (1972) Clinical aspects of insulin antigenicity. Diabetes 21(Suppl. 2): 649–656

    PubMed  CAS  Google Scholar 

  • Schlichtkrull J, Funder J, Munck O (1961) Clinical evaluation of a new insulin preparation. In: 4e Congrès de la Féderation internationale du Diabète, Genève (Demole, ed). Editions Médecine et Hygiène, Genève.1: 303–305

    Google Scholar 

  • Schober E, Schoenle E, Van Dyk J, Wernicke-Panten K (2002) Pediatric Study Group of Insulin Glargine. Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 15: 369–376

    PubMed  CAS  Google Scholar 

  • Scott DA (1934) Crystalline insulin. Biochem J 28: 1592–1602

    PubMed  CAS  Google Scholar 

  • Scott DA, Fisher AM (1936) Studies on insulin with protamine. J Pharmacol Exp Ther 58: 78–92

    CAS  Google Scholar 

  • Thim L, Hansen MZ, Norris K et al. (1986) Secretion and processing of insulin precursors in yeast. Proc Natl Acad Sci USA 83: 6766

    Article  PubMed  CAS  Google Scholar 

  • Vorstand der Deutschen Diabetes-Gesellschaft (1994) Standardisierung der Insulinkonzentration auf 100 E/ml am 01.06.1997 in Deutschland, Frankreich und Italien. Diab Stoffw 3: 445–446

    Google Scholar 

  • Waldhäusl W, Bratusch-Marrain P, Kruse V, Jensen J, Nowotny P, Vierhapper H (1985) Effect of insulin antibodies on insulin pharmacokinetics and glucose utilization in insulindependent diabetic patients. Diabetes 34: 166

    PubMed  Google Scholar 

  • Waldhäusl W, Gasic S, Bratusch-Marrain P, Nowotny P (1983) The 75—g oral glucose tolerance test: effect on splanchnic metabolism of substrates and pancreatic hormone release in healthy man. Diabetologia 25: 489

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

(2005). Insulintherapie. In: Diabetes bei Kindern und Jugendlichen. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-26602-X_8

Download citation

  • DOI: https://doi.org/10.1007/3-540-26602-X_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-21186-0

  • Online ISBN: 978-3-540-26602-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation